company background image
5243

Aarti Drugs BSE:524348 Stock Report

Last Price

₹424.85

Market Cap

₹39.3b

7D

2.3%

1Y

-34.7%

Updated

09 Aug, 2022

Data

Company Financials +
524348 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health4/6
Dividends2/6

524348 Stock Overview

Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally.

Aarti Drugs Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Aarti Drugs
Historical stock prices
Current Share Price₹424.85
52 Week High₹669.30
52 Week Low₹378.40
Beta1.18
1 Month Change5.82%
3 Month Change2.99%
1 Year Change-34.70%
3 Year Change266.92%
5 Year Change230.85%
Change since IPO14,061.67%

Recent News & Updates

Shareholder Returns

524348IN PharmaceuticalsIN Market
7D2.3%0.5%1.0%
1Y-34.7%-14.2%8.0%

Return vs Industry: 524348 underperformed the Indian Pharmaceuticals industry which returned -14.2% over the past year.

Return vs Market: 524348 underperformed the Indian Market which returned 8% over the past year.

Price Volatility

Is 524348's price volatile compared to industry and market?
524348 volatility
524348 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.2%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 524348 is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 524348's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19841,450Prakash Patilhttps://www.aartidrugs.co.in

Aarti Drugs Limited, through its subsidiaries, engages in the pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti-inflammatory, cardioprotectants, antidiarrhoeals, antifungals, antiarthritis/osteoporosis, antibiotics, antidiabetics, Alzheimer’s treatment, sedatives, vitamins, and alcoholism treatment; and pharmaceutical intermediate products comprising tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, nimesulide, and raloxifene. It also offers specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, cipro Q acid, levofloxacin Q acid, methyl nicotinate, N-methyl methane sulphonamide, diphenyl sulphone, norofloxacin Q acid, ofloxacin Q acid, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, para toluene sulphonyl chloride, and sodium benezene sulfinate, as well as para toluene sulphonyl hydrazide and benzene sulphonic acid and sodium salt; and benzyl nicotinate, bisphenol – C, bisphenol – C(chloride), ethyl nicotinate, ethyl para toluene sulphonate, and N-methyl imidazole.

Aarti Drugs Limited Fundamentals Summary

How do Aarti Drugs's earnings and revenue compare to its market cap?
524348 fundamental statistics
Market Cap₹39.34b
Earnings (TTM)₹1.91b
Revenue (TTM)₹25.31b

20.6x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
524348 income statement (TTM)
Revenue₹25.31b
Cost of Revenue₹17.35b
Gross Profit₹7.96b
Other Expenses₹6.05b
Earnings₹1.91b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)20.63
Gross Margin31.45%
Net Profit Margin7.55%
Debt/Equity Ratio52.4%

How did 524348 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

5%

Payout Ratio